Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure and Preserved Ejection Fraction (clinicaltrials.gov)

EMPA-AHF: Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure (clinicaltrials.gov)

Optimize@Home: Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial (clinicaltrials.gov)

CGM Use in Adults With Type 2 Diabetes on Basal Insulin (clinicaltrials.gov)

A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food (clinicaltrials.gov)

Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults (clinicaltrials.gov)

SFRNDM2: Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes (clinicaltrials.gov)

The Effect of Dapagliflozin on Myocardial Strain in Patients With Acute Heart Failure (clinicaltrials.gov)

A Clinical Study in Healthy Adults to See How the Body Processes and How Safe a Tablet That Combines Gemigliptin, Dapagliflozin, and Metformin is, Compared With Taking Zemiglo and Xigduo XR Together While Fasting. (clinicaltrials.gov)

SOTATHROMBUS: Antithrombotic Activities of Sotagliflozin vs. Empagliflozin (clinicaltrials.gov)

Empagliflozin Addition in Modulating Metabolic Disturbances Associated With Olanzapine in Schizophrenia Patients (clinicaltrials.gov)

Vascular Impact of Dapagliflozin in CKD Patients (DAPAVASC) (clinicaltrials.gov)